XT2
XT2 is a potent, orally active, and selective inhibitor of NF-κB-inducing kinase (NIK) with an IC50 of 9.1 nM. XT2 suppresses CCl4-induced upregulation of ALT, a key biomarker of acute liver injury. XT2 also decreases immune cell infiltration into the injured liver tissue. XT2 has the potential for the research of liver inflammatory diseases[1]. XT2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2582816-37-1
UNSPSC
12352005
Target
NF-κB
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/xt2.html
Purity
99.60
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC1=CC=C(C#C[C@@](O)(C2=NC=CS2)C)C=C1C(C3=N4)=CNC3=CN=C4N
Molecular Formula
C19H14FN5OS
Molecular Weight
379.41
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NTRK2 (Neurotrophic Tyrosine Kinase Receptor Type 2) Guinea Pig ELISA Kit
Recombinant Encephalitozoon cuniculi Homeobox protein HD-12 (HD-12)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-12 (HD-12)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-12 (HD-12)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-12 (HD-12)